Skip to main content
. 2022 Oct 25;20:407. doi: 10.1186/s12916-022-02601-z

Fig. 3.

Fig. 3

Cost-effectiveness acceptability curve of enalapril-folic acid versus enalapril. Cost-effectiveness acceptability curve of enalapril-folic acid versus enalapril, for the base case (red line), life year (blue), and scenario analyses: no effect of enalapril-folic acid after 5 years (green); no effect of enalapril-folic acid after 10 years (orange); enalapril-folic acid at 1/2 price (gray). QALY, quality-adjusted life-year